Paul Hartmann AG header image

Paul Hartmann AG

PHH2

Equity

ISIN DE0007474041 / Valor 1547181

Deutsche Boerse AG (2025-11-21)
EUR 221.00-1.34%

Paul Hartmann AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Paul Hartmann AG is a German company with a long history in the healthcare sector, specializing in the production and distribution of medical and hygiene products. Originally established as a textile business in the late 18th century, the company transitioned into the healthcare industry in the 1870s. Today, Hartmann is recognized for its comprehensive range of products, including wound management solutions, incontinence care, and infection prevention products. The company serves a global market, providing essential medical supplies to hospitals, healthcare professionals, and consumers. With a focus on innovation and quality, Hartmann continues to expand its product offerings to meet the evolving needs of the healthcare industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (06.10.2025):

In the first quarter of 2025, Paul Hartmann AG reported strong financial performance, maintaining its full-year outlook despite rising material prices and tariffs.

Sales Revenue Growth

From January to March 2025, Paul Hartmann AG achieved organic sales growth of 1.3%, resulting in sales revenues of EUR 607.3 million.

Adjusted EBITDA

Adjusted EBITDA for the quarter was EUR 70.9 million, an increase of EUR 1.9 million compared to the previous year, with an adjusted EBITDA margin of 11.7%.

Product Launches and Transformation Program

New product launches as part of the Transformation Program are expected to further contribute to sales growth throughout the year.

Segment Performance

The Incontinence Management and Wound Care segments saw continued growth in key markets, while Infection Management exhibited mixed results.

Outlook

Paul Hartmann AG anticipates moderate organic sales growth and adjusted EBITDA in the range of EUR 260 to 300 million for the 2025 financial year.

Summarized from source with an LLMView Source

Key figures

3.27%1Y
-4.33%3Y
-35.4%5Y

Performance

24.6%1Y
28.3%3Y
27.4%5Y

Volatility

Market cap

904 M

Market cap (USD)

Daily traded volume (Shares)

110

Daily traded volume (Shares)

1 day high/low

222 / 222

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 85.13
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%USD 21.18
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 26.60
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.62%USD 101.12
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 13.91
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%EUR 18.44
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%DKK 580.20
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 5.03
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%SEK 260.90
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%SEK 342.20